3T3 cells in adipocytic conversion.
3T3 are murine cells of an established heteroploid cellular line. Some clones of this cellular line, when cultured under adequate conditions differentiate into adipocytes. During the process of differentiation, the cells undergo a change from the elongated fibroblastic shape to a round or oval form and accumulate small drops of lipids within their cytoplasma. These lipid drops fuse into one large drop which displaces the nucleus towards the periphery, giving the cell the aspect of a mature adipocyte of white adipose tissue. The cells not only change their morphology, but they also present important biochemical changes. They show a simultaneous increase in triglyceride synthesis and activity of lipogenic enzymes. There is also an increase in the response of the activity of various hormones and the de novo synthesis of the receptors to such hormones, as insulin and ACTH. During the process of differentiation important changes occur in the synthesis of various proteins, such as actin, tubulin, and other proteins which also make up the cellular cytoskeleton, forming part of the lipid transportation within the adipose cell. The adipocytic differentiation of 3T3 cells depends on adipogenic serum factors used in the supplementary culture medium. These adipogenic factors seem to play an important role in the development of adipose tissue. There are hormones, chemical agents and serum factors which modulate adipocytic differentiation. The clone must be susceptible to adipocytic differentiation, it must reach a quiescent state and find itself in adipogenic conditions for the 3T3 cells to differentiate into adipocytes. It must also carry out an DNA synthesis which is an expression of the new phenotype. The differentiation of 3T3 cells in terminal. The fact that these cells present an adipocytic conversion under physiologic conditions and with adipogenic hormones which exist in the whole animal has been demonstrated. All of these characteristics show that the 3T3 cells may be used as an adequate experimental system to analyze the events which occur during the differentiation and development of adipose tissue.
O'Shea Alvarez
M S
MS
Hospital de Especialidades Centro Médico Nacional, Instituto Mexicano del Seguro Social, D.F.
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D016475:3T3 Cells / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D000273:Adipose Tissue / Q000166:cytology* / Q000378:metabolism; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000818:Animals; D002415:Cats / Q000097:blood; D002417:Cattle / Q000097:blood; D002453:Cell Cycle / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects; D002478:Cells, Cultured; D003470:Culture Media / Q000494:pharmacology; D000242:Cyclic AMP / Q000031:analogs & derivatives / Q000494:pharmacology; D003598:Cytoskeletal Proteins / Q000096:biosynthesis; D004261:DNA Replication; D015237:Dinoprost / Q000494:pharmacology; D004798:Enzymes / Q000096:biosynthesis; D015870:Gene Expression; D006728:Hormones / Q000494:pharmacology; D008055:Lipids / Q000096:biosynthesis; D051379:Mice; D011956:Receptors, Cell Surface / Q000096:biosynthesis
D000318:Adrenergic beta-Agonists; D003470:Culture Media; D003598:Cytoskeletal Proteins; D004798:Enzymes; D006728:Hormones; D008055:Lipids; D011956:Receptors, Cell Surface; D015237:Dinoprost; D000242:Cyclic AMP; D015056:1-Methyl-3-isobutylxanthine